NEW YORK, Nov. 25, 2002 (PRIMEZONE) -- Beatie and Osborn LLP, one of the law firms appointed by the Delaware Chancery Court to represent shareholders in the litigation involving NCS HealthCare, Inc. (OTCBB:NCSS), hereby informs NCS shareholders that if the merger with Genesis Health Ventures, Inc. (Nasdaq:GHVI) proceeds, NCS shareholders may be entitled to a fair value Appraisal of their shares in lieu of Genesis' offering price. An Appraisal proceeding is an opportunity for NCS shareholders to receive more for their NCS shares than is currently provided in the proposal merger with Genesis.
A shareholder who successfully exercises his/her appraisal rights will have the value of their shares determined by the Delaware Chancery Court. NCS shareholders who wish to learn more about appraisal rights should view the information available at www.bandolaw.com.
For more information please contact:
Eduard Korsinsky, Esq. Benjamin D. Coleman, Legal Assistant Beatie and Osborn LLP 521 Fifth Avenue, 34th Floor New York, New York 10175 Telephone: (800) 891-6305 Facsimile: (212) 888-9664 E-mail: clientrelations@bandolaw.com Website: http://www.bandolaw.com
More information on this and other class actions can be found on the Class Action Newsline at www.primezone.com/ca.